Chris Brigham is a Private Client Senior Research Associate at Bernstein. He joined Bernstein in 2018 as a member of the US Portfolio Strategy team. Prior to Bernstein, he worked in finance and strategy for EpiBone, a biotechnology startup. He has previously worked as a research analyst at Longview Asset Management and Tiresias Capital (Omni Partners) and as an event-driven analyst and trader at Bank of America Merrill Lynch. Chris earned his MBA from Columbia Business School, where he completed the Value Investing Program, and graduated Phi Beta Kappa with a BA in Economics from Claremont McKenna College. He completed the General Course at the London School of Economics and is a CFA charterholder. Location: New York